BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2018
View Archived Issues
Cellenkos manufacturing facility is successfully registered as GMP compliant with the FDA
Read More
Acesion Pharma cleared to conduct phase I study of AP-30663
Read More
Janssen submits MAA to EMA for apalutamide for nonmetastatic CRPC
Read More
Phase II trials of BI-409306 in Alzheimer's disease do not meet efficacy endpoints
Read More
Novo Nordisk's Ozempic approved in E.U.
Read More
Boehringer Ingelheim initiates phase I study of BI-1291583
Read More
Aravive studies AVB-S6-500 in healthy volunteers
Read More
Lundbeck updates progress of fourth quarter 2017
Read More
Tychan initiates phase Ia trial of first-in-class Zika antibody tyzivumab
Read More
Puma presents clinical data on neratinib in patients with HER2/3 mutant cancers
Read More
Phase III quality of life data reported for turoctocog alfa pegol in hemophilia A
Read More
Kissei presents novel CGRP antagonists
Read More
Retrophin divulges new pantetheine derivatives for neurodegeneration
Read More
New phase I/II trial evaluates lentiviral gene transfer for SCID-X1
Read More
Achaogen discloses novel ACC inhibitors for bacterial infections
Read More
Novel USP19 inhibitors presented by Almac Discovery
Read More
Toray Industries identifies MALT1 inhibitors
Read More
Roivant and Poxel sign development and license agreement for imeglimin
Read More
Seattle Genetics and Pieris Pharmaceuticals enter immune-oncology collaboration
Read More
Scholar Rock's SRK-015 antibody inhibits muscle wasting by binding myostatin precursors
Read More
